Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma
Clinical trial NCT01421927 · TERMINATED
Trial details
- NCT number
- NCT01421927
- Sponsor
- University Hospital, Bordeaux
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-10-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.